First Horizon Corporation (FHN) concluded trading on Thursday at a closing price of $19.26, with 4.43 million shares of worth about $85.28 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.36% during that period and on May 08, 2025 the price saw a gain of about 3.55%. Currently the company’s common shares owned by public are about 507.00M shares, out of which, 499.85M shares are available for trading.
Stock saw a price change of 5.36% in past 5 days and over the past one month there was a price change of 16.66%. Year-to-date (YTD), FHN shares are showing a performance of -4.37% which increased to 22.68% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $14.09 but also hit the highest price of $22.44 during that period. The average intraday trading volume for First Horizon Corporation shares is 6.26 million. The stock is currently trading 8.08% above its 20-day simple moving average (SMA20), while that difference is up 4.04% for SMA50 and it goes to 4.30% higher than SMA200.
First Horizon Corporation (NYSE: FHN) currently have 507.00M outstanding shares and institutions hold larger chunk of about 86.76% of that.
The stock has a current market capitalization of $9.76B and its 3Y-monthly beta is at 0.61. PE ratio of stock for trailing 12 months is 13.41, while it has posted earnings per share of $1.44 in the same period. Its PEG reads 1.28 while making debt-to-equity ratio of 0.63. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for FHN, volatility over the week remained 2.21% while standing at 3.89% over the month.
Stock’s fiscal year EPS is expected to rise by 9.58% while it is estimated to increase by 9.99% in next year. EPS is likely to grow at an annualized rate of 10.44% for next 5-years, compared to annual growth of -0.31% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Robert W. Baird on April 07, 2025 offering an Outperform rating for the stock and assigned a target price of $22 to it. On September 24, 2024, Wedbush Downgrade their recommendations, while on July 18, 2024, Raymond James Downgrade their ratings for the stock with a price target of $18. Stock get a Mkt perform rating from Keefe Bruyette on July 17, 2024.
